A commentary on interstitial pneumonitis induced by docetaxel: Clinical cases and systematic review of the literature

Tumori

Volumn 101, Issue 3, 2015, Pages e92-e95

  Genestreti, Giovenzio ^a   Di Battista, Monica ^a   Trisolini, Rocco ^a   Denicolò, Fabio ^b   Valli, Mirca ^c   Lazzari Agli, Luigi Arcangelo ^d   Piaz, Giorgia Dal ^a   De Biase, Dario ^a   Bartolotti, Marco ^a   Cavallo, Giovanna ^a   Brandes, Alba A ^a  

^a Azienda USL di Bologna   (Italy)

^b Cattolica AUSL della Romagna   (Italy)

^c Infermi Hospital   (Italy)

^d Ceccarini Hospital   (Italy)

Author keywords

Docetaxel; Drug induced toxicity; Lung cancer; Pulmonary injury

Indexed keywords

C REACTIVE PROTEIN; CARBOPLATIN; DOCETAXEL; GEMCITABINE; PREDNISONE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; TAXOID;

ABNORMAL RESPIRATORY SOUND; ADRENAL METASTASIS; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRACKLE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MACROPHAGE; MEDIASTINUM LYMPHADENOPATHY; NEUTROPHIL COUNT; NON SMALL CELL LUNG CANCER; OXYGEN SATURATION; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; ADENOCARCINOMA; ALVEOLITIS, EXTRINSIC ALLERGIC; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CHEMICALLY INDUCED; CONVALESCENCE; DRUG ADMINISTRATION; FEMALE; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; PATHOLOGY; PATHOPHYSIOLOGY; SPIROMETRY;

ADENOCARCINOMA; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; PREDNISONE; RECOVERY OF FUNCTION; SPIROMETRY; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938233456     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.5301/tj.5000275     Document Type: Article

References (15)

1. Kunitoh H, Watanabe K, Onoshi T, Furuse K, Niitani H, Taguchi T. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol. 1996;14(5):1649-1655.
2. Merad M, Le Cesne A, Baldeyrou P, Mesurolle B, Le Chevalier T. Docetaxel and interstitial pulmonary injury. Ann Oncol. 1997;8(2):191-194.
3. Etienne B, Pé rol M. Nesme P, Vuillermoz S, Robinet G, Guérin JC: Acute diffuse interstitial pneumopathy following docetaxel (Taxotere). Apropos of 2 cases. Rev Mal Respir. 1998; 15(2):199-203.
4. Wang GS, Yang KY , Perng RP. Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). Br J Cancer. 2001;85(9):1247-1250.
5. Read WL, Mortimer JE, Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer. 2002;94(3):847-853.
6. Grande C, Villanueva MJ, Huidobro G, Casal J. Docetaxelinduced interstitial pneumonitis following non-small-cell lung cancer treatment. Clin Transl Oncol. 2007;9(9):578-581.
7. Hasskarl J, Schroettner P, von den Berg A, et al. Severe organizing pneumonia after two cycles of docetaxel as fourth-line chemotherapy for advanced non-small cell carcinoma of the lung. Case Rep Oncol. 2009;2(1):1 2-19.
8. Komaki C, Niwa T, Tatsuoka H, Inoue Y. A case of docetaxelinduced acute lung injury refractory to treatment. Gan To Kagaku Ryoho. 2012;39(1):103-105.
9. Tamiya A, Naito T, Miura S, et al. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer. Anticancer Res. 2012;32(3):1103-1106.
10. Min BD, Kang HW, Kim WT, et al. Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer. Korean J Urol. 2012;53(5):371-374.
11. Kim S, Tannock I, Sridhar S, Seki J, Bordeleau L. Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients. J Oncol Pharm Pract. 2012;18(2):311-315.
12. Storaas E, Holmaas G, Gravdal K, Børretzen A, Eikesdal HP. Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature. Acta Oncol. 2013;52(5):1034-1038.
13. Nagata S, Ueda N, Yoshida Y, Matsuda H, M aehara Y. Severe interstitial pneumonitis associated with the administration of taxanes. J Infect Chemother. 2010;16(5):340-344.
14. Chen YM, Shih JF, Perng RP, Tsai CM, Whang-Peng J. A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy. Chest. 2006;129(4):1031-1038.
15. Gurram MK, Pulivarthi S, M cGary CT. Fatal hypersensitivity pneumonitis associated with docetaxel. Tumori. 2013;99(3): e100-e103.